Galapagos NV
GLPG
#4874
Rank
S$2.45 B
Marketcap
S$36.60
Share price
-0.14%
Change (1 day)
9.37%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): S-$0.42

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is S-$0.43. In 2024 the company made an earnings per share (EPS) of S$1.49 a decrease over its 2023 EPS that were of S$4.53.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.42-128.48%
2024S$1.49-67.16%
2023S$4.53-199.64%
2022S-$4.5599.03%
2021S-$2.29-68.98%
2020S-$7.37-298.06%
2019S$3.72-554.64%
2018S-$0.82-77.18%
2017S-$3.59-326.21%
2016S$1.59-134.19%
2015S-$4.64-371.34%
2014S$1.71-445.98%
2013S-$0.4932.88%
2012S-$0.37-82.07%
2011S-$2.07-817.9%
2010S$0.2912.73%
2009S$0.26-120.79%
2008S-$1.23-37.67%
2007S-$1.9839.64%
2006S-$1.4228.17%
2005S-$1.116.25%
2004S-$1.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.23-3,384.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.79-1,205.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$3.06-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.64-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$9.34-2,255.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$7.58-1,848.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$4.82-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
S-$0.78 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$1.58-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel